| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014049 |
| Receipt No. | R000016357 |
| Official scientific title of the study | An observation study of an effect of pneumoperitoneum on perfusion of extremities |
| Date of disclosure of the study information | 2014/06/01 |
| Last modified on | 2016/05/31 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | An observation study of an effect of pneumoperitoneum on perfusion of extremities | |
| Title of the study (Brief title) | An observation study of an effect of pneumoperitoneum on perfusion of extremities | |
| Region |
|
|
| Condition | ||
| Condition | Patients who recieced laparoscopic surgery with pneumoperitonium | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Pneumoperitonium is reported to influence cardiovascular system of the patients who underwent laparoscopic surgery. However, the effect of pneumoperitonium on perfusion of the extremities is not well-known. We observe the effect of pneumoperitonium on the perfusion of extremities. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood pressure and regional saturation of oxygen of extremities at the time of pre and post pneumoperitonium. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent laparoscopic surgery with pneumoperitonium | |||
| Key exclusion criteria | Patients with renal replacement therapy, Emergency surgery. | |||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroki Iida |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Pain Medicine |
| Address | 1-1 Yanagido, Gifu, Gifu 501-1194, Japan |
| TEL | +81-58-230-6404 |
| iida@gifu-u.ac.jp | |
| Public contact | |
| Name of contact person | Kimito Minami |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Pain Medicine |
| Address | 1-1 Yanagido, Gifu, Gifu, Japan |
| TEL | +81-58-230-6404 |
| Homepage URL | |
| nann_5115@ybb.ne.jp | |
| Sponsor | |
| Institute | Gifu University Graduate School of Medicine, Department of Anesthesiology and Pain Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | we observe blood pressure and regional saturation of oxygenation of extremities at the thme of pre and post pneumperitonium. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016357 |